FindTrial
Sign In

Comparison of Intraperitoneal instillation of Bupivacaine with Magnesium sulphate versus Intravenous analgesics drugs for post operative pain relief after Laparoscopic cholecystectomy.

Comparison of Intraperitoneal instillation of Bupivacaine with Magnesium sulphate versus Intravenous analgesics drugs for post operative pain relief after Laparoscopic cholecystectomy - A Randomized controlled study . - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075335
Enrollment
52
Registered
2024-10-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K801- Calculus of gallbladder with othercholecystitis

Interventions

Intervention1: Intraperitoneal instillation of Bupivacaine with Magnesium sulphate: At the end of gall bladder removal, 0.25% of bupivacaine +500mg magnesium sulphate 20ml will be instilled in the g

Sponsors

HERITAGE INSTITUTE OF MEDICAL SCIENCES
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion Criteria 1. Patients undergoing elective laparoscopic cholecystectomy, 2. Patients of ASA grade 1 and 2 and 3. Patients aged between 20 to 60 years

Exclusion criteria

Exclusion criteria: Exclusion Criteria 1. Patient who will give negative informed consent . 2. Patients with allergy to the study drugs (MgSO4, Bupivacaine ,Paracetamol) 3. Chronic alcoholics, 4. Patients with heart block or renal failure . 5. Patients with peritoneal drain after surgery. 6. Patients treated with calcium channel blockers

Design outcomes

Primary

MeasureTime frame
To compare post operative pain in laparoscopic cholecystectomy patients who will receive intravenous (IV) analgesics drugs versus those who will receive intraperitoneal Bupivacaine with Magnesium sulphate. Timepoint: AT 30 mins, 1 hour, 2 hour, 3 hour,6 hour, 12hour, 24hour—

Secondary

MeasureTime frame
To assess changes in hemodynamic response and any adverse effects.Timepoint: 30 mins, 1hour, 2hour,3hour, 6 hour, 12 hour ,24 hour—

Countries

India

Contacts

Public ContactDr Kajal

Heritage institute of medical sciences

pushkarranjanbhu@gmail.com9415986684

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026